Financials
- Market Capitalization 1 B
- Employee 55
- Founded 2003
- CEO N/A
- Website www.candeltx.com
- Headquarter Delaware, United States
- FIGI BBG00N0D4Z71
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2441 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.29 USD | -1.29% | -1.29% | -1.29% | +104.46% | 1.02 B USD | ||
| 2452 | ABUS Arbutus Biopharma Corporation - Common Stock | 5.07 USD | -1.93% | -2.12% | +18.18% | +37.40% | 1.00 B USD | ||
| 2456 | IMMX Immix Biopharma, Inc. - Common Stock | 13.94 USD | -2.59% | +2.05% | +68.36% | +530.77% | 997.26 M USD | ||
| 2457 | WVE Wave Life Sciences Ltd. - Ordinary Shares | 5.04 USD | -2.33% | -4.36% | -10.32% | -29.61% | 993.12 M USD |
Frequently asked questions about Candel Therapeutics, Inc. Common Stock
What is the Candel Therapeutics, Inc. Common Stock stock price today?
The current price of Candel Therapeutics, Inc. Common Stock (CADL) is 13.07. Over the past 24 hours, the stock has changed by -4.95%. Follow the CADL chart for real-time price dynamics.
What is the stock ticker of Candel Therapeutics, Inc. Common Stock?
Candel Therapeutics, Inc. Common Stock trades under the ticker CADL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Candel Therapeutics, Inc. Common Stock stock going up?
CADL has changed by +0.69% over the last week, +37.43% over the last month, and +124.96% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Candel Therapeutics, Inc. Common Stock?
Candel Therapeutics, Inc. Common Stock currently has a market capitalization of 1 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Candel Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Candel Therapeutics, Inc. Common Stock reported earnings of -0.52 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Candel Therapeutics, Inc. Common Stock net income for the last quarter?
Candel Therapeutics, Inc. Common Stock reported net income of -38.91 M for the last quarter. The previous quarter showed -8.86 M, which means net income changed by -339.06%.
How many employees does Candel Therapeutics, Inc. Common Stock have?
As of the latest available data, Candel Therapeutics, Inc. Common Stock has 55 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Candel Therapeutics, Inc. Common Stock stock?
You can buy Candel Therapeutics, Inc. Common Stock (CADL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Candel Therapeutics, Inc. Common Stock stock?
Investing in Candel Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CADL chart and related analysis on metatrader.com as part of your research.